Anti-transthyretin Antibodies


The invention provides antibodies that specifically bind transthyretin (TTR). The antibodies can be used for treating or effecting prophylaxis of diseases or disorders associated with TTR accumulation or accumulation of TTR deposits (e.g., TTR amyloidosis). The antibodies can also be used for diagnosing TTR amyloidosis and inhibiting or reducing aggregation of TTR, among other applications.

Family Member PDF
Family Member Preview
These are the images from a related family member, as the full document isn't yet available to us from the patent office.
Document History
  • Publication: Aug 4, 2016
  • Application: Jan 28, 2016
    WO IB 2016050415 W
  • Priority: Dec 11, 2015
    US US 201562266556 P
  • Priority: Jan 28, 2015
    US US 201562109002 P

Download Citation

Sign in to the Lens